These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2151756)

  • 1. The relationship between suppression of acidity and gastric ulcer healing rates.
    Howden CW; Hunt RH
    Aliment Pharmacol Ther; 1990 Feb; 4(1):25-33. PubMed ID: 2151756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between acid suppression and peptic ulcer healing.
    Hunt RH; Howden CW; Jones DB; Burget DW; Kerr GD
    Scand J Gastroenterol Suppl; 1986; 125():22-31. PubMed ID: 3469740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates.
    Howden CW; Jones DB; Peace KE; Burget DW; Hunt RH
    Dig Dis Sci; 1988 May; 33(5):619-24. PubMed ID: 3282850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
    Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
    Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing acid suppression for treatment of acid-related diseases.
    Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids.
    Bonten MJ; Gaillard CA; van der Geest S; van Tiel FH; Beysens AJ; Smeets HG; Stobberingh EE
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1825-34. PubMed ID: 8520743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate acid suppression in the treatment of acid-related conditions.
    Howden CW
    Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.
    Burget DW; Chiverton SG; Hunt RH
    Gastroenterology; 1990 Aug; 99(2):345-51. PubMed ID: 2142113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.
    Jablonská M
    Dig Dis Sci; 1995 Sep; 40(9):2016-8. PubMed ID: 7555458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the gastric stump ulcer: an open study with five drugs.
    Janke A; Stasiewicz J; Namiot Z; Szalaj W
    Hepatogastroenterology; 2000; 47(34):1195-8. PubMed ID: 11020913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
    Bianchi Porro G; Parente F; Sangaletti O
    Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
    Naesdal J; Bodemar G; Walan A
    Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Howden CW; Jones DB; Burget DW; Hunt RH
    Gut; 1986 Sep; 27(9):1058-61. PubMed ID: 3758819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamism of cytoprotective and antisecretory drugs in patients with unhealed gastric and duodenal ulcers.
    Mózsik G; Hunyady B; Garamszegi M; Németh A; Pakodi F; Vincze A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S88-92. PubMed ID: 7881027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [H. pylori eradication therapy compared with antisecretory non-eradication therapy for the prevention of recurrent bleeding stomach ulcer].
    Dam A; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2005 Jan; 167(5):497-9. PubMed ID: 15745169
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the ulcer healing effect of different cytoprotective and antisecretory drugs in gastric ulcer patients.
    Garamszegi M; Németh A; Patty I; Tárnok F; Mózsik G; Vincze A; Sütö G; Jávor T
    Acta Physiol Hung; 1990; 75 Suppl():127-8. PubMed ID: 2371840
    [No Abstract]   [Full Text] [Related]  

  • 19. Degrees of acid suppression and ulcer healing: dosage considerations.
    Pounder RE
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():5-13. PubMed ID: 1888835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ulcer therapy without acid inhibition].
    Koelz HR
    Schweiz Med Wochenschr; 1984 May; 114(20):686-93. PubMed ID: 6547542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.